KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Gilead Sciences (GILD) Other Operating Expenses (2016 - 2026)

Gilead Sciences filings provide 17 years of Other Operating Expenses readings, the most recent being $2.6 billion for Q4 2025.

  • On a quarterly basis, Other Operating Expenses rose 63.35% to $2.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $7.8 billion, a 48.01% decrease, with the full-year FY2025 number at $7.8 billion, down 48.01% from a year prior.
  • Other Operating Expenses hit $2.6 billion in Q4 2025 for Gilead Sciences, up from $1.7 billion in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $8.1 billion in Q1 2024 to a low of $1.3 billion in Q3 2021.
  • Median Other Operating Expenses over the past 5 years was $1.8 billion (2022), compared with a mean of $2.5 billion.
  • Biggest five-year swings in Other Operating Expenses: surged 331.31% in 2024 and later tumbled 77.9% in 2025.
  • Gilead Sciences' Other Operating Expenses stood at $3.3 billion in 2021, then decreased by 3.88% to $3.2 billion in 2022, then decreased by 21.53% to $2.5 billion in 2023, then tumbled by 36.89% to $1.6 billion in 2024, then soared by 63.35% to $2.6 billion in 2025.
  • The last three reported values for Other Operating Expenses were $2.6 billion (Q4 2025), $1.7 billion (Q3 2025), and $1.8 billion (Q2 2025) per Business Quant data.